Malvern image analysis system measures sub-visible particulates in biotherapeutics

Specialists at Malvern Panalytical have demonstrated the application of dynamic particle image analysis to the measurement of sub-visible particulates in biological therapeutics, using the Sysmex FPIA-3000 particle characterization system.

This is an important advance since protein suspensions tend to contain sub-visible particulates that may pose health risks or affect the performance of biological therapeutics. At sizes below 10 microns, these particulates have proved difficult to characterize fully using traditional analytical techniques. This has prompted investigations into new ways of detecting the presence, measuring the size and also characterizing the shape and intensity (transparency) of these particulates to ensure product safety and performance. An application note on the subject; “Measuring Sub-Visible Particulates in Biological Therapeutics using the Sysmex FPIA-3000” can be downloaded from the Malvern Panalytical website at: https://www.malvernpanalytical.com/en 

The Sysmex FPIA-3000 from Malvern Panalytical is a dynamic particle image analysis system that incorporates optical imaging of a sample once it has been aligned by a unique sheath-flow cell. Sample alignment ensures that every single particle, from 0.8 µm to 300 µm, has its largest surface area imaged. Obtaining the maximum dimension is critical to investigations focused on safety. However, for development studies requiring further information, the system also delivers high quality, high resolution images enhanced by contrast control that enables the distinction of primary particles, foreign matter and agglomerates. This type of additional detail can provide beneficial control over the final product.

Further information on method selection techniques are outlined in the new application note and both this, and additional details on the Sysmex FPIA-3000 particle characterization instrument can be found at: https://www.malvernpanalytical.com/en

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2023, March 24). Malvern image analysis system measures sub-visible particulates in biotherapeutics. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20100318/Malvern-image-analysis-system-measures-sub-visible-particulates-in-biotherapeutics.aspx.

  • MLA

    Malvern Panalytical. "Malvern image analysis system measures sub-visible particulates in biotherapeutics". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20100318/Malvern-image-analysis-system-measures-sub-visible-particulates-in-biotherapeutics.aspx>.

  • Chicago

    Malvern Panalytical. "Malvern image analysis system measures sub-visible particulates in biotherapeutics". News-Medical. https://www.news-medical.net/news/20100318/Malvern-image-analysis-system-measures-sub-visible-particulates-in-biotherapeutics.aspx. (accessed November 21, 2024).

  • Harvard

    Malvern Panalytical. 2023. Malvern image analysis system measures sub-visible particulates in biotherapeutics. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20100318/Malvern-image-analysis-system-measures-sub-visible-particulates-in-biotherapeutics.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Creoptix launches new WAVEcontrol software to deliver automated, flexible and intuitive label-free interaction analysis for biologics drug-discovery